DECREASED ALPHA-SECRETASE-CLEAVED AMYLOID PRECURSOR PROTEIN AS A DIAGNOSTIC MARKER FOR ALZHEIMERS-DISEASE

被引:145
作者
LANNFELT, L [1 ]
BASUN, H [1 ]
WAHLUND, LO [1 ]
ROWE, BA [1 ]
WAGNER, SL [1 ]
机构
[1] SIBIA,LA JOLLA,CA 92037
关键词
D O I
10.1038/nm0895-829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neuropathologic hallmarks of Alzheimer's disease (AD) are extracellular plaques and intracellular neurofibrillary tangles. A constituent of senile plaques in AD is beta-amyloid, a hydrophobic peptide of 39-43 amino acids(1) and a fragment of the amyloid precursor protein (APP). APP can be metabolized by at least two pathways, one of which involves generation of soluble APP by an unidentified enzyme named alpha-secretase. This cleavage generates alpha-secretase-cleaved, soluble APP (alpha-sAPP), which in this investigation was measured by a new assay in cerebrospinal fluid (CSF) from members of a Swedish AD family with a pathogenic mutation at APP(670/671) (ref. 2). Family members who carry the mutation and are diagnosed with AD had low levels of alpha-sAPP (160 +/- 48 ng ml(-1)), with no overlap compared with non-carriers (257 +/- 48 ng ml(-1)). Carriers of the presymptomatic mutation showed intermediate alpha-sAPP levels. Today there exists no antemortem marker in AD with sufficient sensitivity and specificity, but measurement of alpha-sAPP represents a new and promising diagnostic marker.
引用
收藏
页码:829 / 832
页数:4
相关论文
共 20 条
[1]   A LARGE SWEDISH FAMILY WITH ALZHEIMERS-DISEASE WITH A CODON-670/671 AMYLOID PRECURSOR PROTEIN MUTATION - A CLINICAL AND GENEALOGICAL INVESTIGATION [J].
AXELMAN, K ;
BASUN, H ;
WINBLAD, B ;
LANNFELT, L .
ARCHIVES OF NEUROLOGY, 1994, 51 (12) :1193-1197
[2]   RELEASE OF EXCESS AMYLOID BETA-PROTEIN FROM A MUTANT AMYLOID BETA-PROTEIN PRECURSOR [J].
CAI, XD ;
GOLDE, TE ;
YOUNKIN, SG .
SCIENCE, 1993, 259 (5094) :514-516
[3]   EXCESSIVE PRODUCTION OF AMYLOID BETA-PROTEIN BY PERIPHERAL CELLS OF SYMPTOMATIC AND PRESYMPTOMATIC PATIENTS CARRYING THE SWEDISH FAMILIAL ALZHEIMER-DISEASE MUTATION [J].
CITRON, M ;
VIGOPELFREY, C ;
TEPLOW, DB ;
MILLER, C ;
SCHENK, D ;
JOHNSTON, J ;
WINBLAD, B ;
VENIZELOS, N ;
LANNFELT, L ;
SELKOE, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) :11993-11997
[4]   MUTATION OF THE BETA-AMYLOID PRECURSOR PROTEIN IN FAMILIAL ALZHEIMERS-DISEASE INCREASES BETA-PROTEIN PRODUCTION [J].
CITRON, M ;
OLTERSDORF, T ;
HAASS, C ;
MCCONLOGUE, L ;
HUNG, AY ;
SEUBERT, P ;
VIGOPELFREY, C ;
LIEBERBURG, I ;
SELKOE, DJ .
NATURE, 1992, 360 (6405) :672-674
[5]   ALTERED CLEAVAGE AND SECRETION OF A RECOMBINANT BETA-APP BEARING THE SWEDISH FAMILIAL ALZHEIMERS-DISEASE MUTATION [J].
FELSENSTEIN, KM ;
HUNIHAN, LW ;
ROBERTS, SB .
NATURE GENETICS, 1994, 6 (03) :251-256
[6]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[7]  
HARDY J, 1992, NEUROSCI FACTS, V3, P65
[8]   ANALYSIS AND QUANTITATION OF THE BETA-AMYLOID PRECURSOR PROTEIN IN THE CEREBROSPINAL-FLUID OF ALZHEIMERS-DISEASE PATIENTS WITH A MONOCLONAL ANTIBODY-BASED IMMUNOASSAY [J].
HENRIKSSON, T ;
BARBOUR, RM ;
BRAA, S ;
WARD, P ;
FRITZ, LC ;
JOHNSONWOOD, K ;
CHUNG, HD ;
BURKE, W ;
REINIKAINEN, KJ ;
RIEKKINEN, P ;
SCHENK, DB .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (03) :1037-1042
[9]   INCREASED BETA-AMYLOID RELEASE AND LEVELS OF AMYLOID PRECURSOR PROTEIN (APP) IN FIBROBLAST CELL-LINES FROM FAMILY MEMBERS WITH THE SWEDISH ALZHEIMERS-DISEASE APP670/671 MUTATION [J].
JOHNSTON, JA ;
COWBURN, RF ;
NORGREN, S ;
WIEHAGER, B ;
VENIZELOS, N ;
WINBLAD, B ;
VIGOPELFREY, C ;
SCHENK, D ;
LANNFELT, L ;
ONEILL, C .
FEBS LETTERS, 1994, 354 (03) :274-278
[10]   LOW-FREQUENCY OF THE APP-670/671 MUTATION IN FAMILIAL ALZHEIMERS-DISEASE IN SWEDEN [J].
LANNFELT, L ;
VIITANEN, M ;
JOHANSSON, K ;
AXELMAN, K ;
LILIUS, L ;
ALMQVIST, E ;
WINBLAD, B .
NEUROSCIENCE LETTERS, 1993, 153 (01) :85-87